New blood tests to diagnose brain injury after trauma
Predictive accuracy of acute astroglial compromise biomarkers after traumatic brain injury
['FUNDING_OTHER'] · UNIVERSITY OF CALIFORNIA LOS ANGELES · NIH-10468982
This study is looking for new blood tests that can help doctors quickly understand how serious a brain injury is after someone has had a traumatic brain injury, so they can provide better care and treatment.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA LOS ANGELES (nih funded) |
| Locations | 1 site (LOS ANGELES, UNITED STATES) |
| Trial ID | NIH-10468982 on ClinicalTrials.gov |
What this research studies
This research focuses on developing blood-based biomarkers that can quickly and accurately assess the extent of brain injury in patients who have experienced traumatic brain injury (TBI). By analyzing specific markers released from astroglial cells, the study aims to bridge the gap between laboratory findings and clinical application, allowing for better monitoring and diagnosis of TBI severity. The approach involves validating these biomarkers in various patient cohorts to ensure their effectiveness in real-world settings. Ultimately, this research seeks to provide healthcare professionals with reliable tools for early intervention and treatment planning.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have recently suffered a traumatic brain injury, regardless of severity.
Not a fit: Patients with chronic brain injuries or those who do not have a recent history of trauma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more accurate diagnoses of traumatic brain injuries, improving patient outcomes.
How similar studies have performed: Previous research has shown promise in using blood-based biomarkers for diagnosing brain injuries, indicating that this approach has potential for success.
Where this research is happening
LOS ANGELES, UNITED STATES
- UNIVERSITY OF CALIFORNIA LOS ANGELES — LOS ANGELES, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HARRIS, NEIL — UNIVERSITY OF CALIFORNIA LOS ANGELES
- Study coordinator: HARRIS, NEIL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.